oncolytic - Robuta Search

https://www.surrey.ac.uk/research-projects/combining-oncolytic-viral-therapy-and-immune-checkpoint-blockadeto-achieve-optimal-prostate-cancer Combining oncolytic viral therapy and immune checkpoint blockadeto achieve optimal prostate cancer... oncolytic viral therapy immune checkpoint https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1530583/full Frontiers | Effect of bispecific recombinant oncolytic adenovirus carrying apoptin on apoptosis of... ObjectiveIn this study, breast cancer cell line MCF-7 was infected with recombinant oncolytic adenovirus Ad-VT expressing apopsin protein, and its anti-tumou... oncolytic adenovirus frontiers effect recombinant https://www.hmpgloballearningnetwork.com/site/frmc/conference-coverage/measuring-pandemics-impact-oral-oncolytic-adherence Measuring the Pandemic's Impact on Oral Oncolytic Adherence Researchers at AMCP 2023 studied the number of prescription fills and therapy changes to determine how COVID-19 impacted adherence to oral oncolytic agents.... the pandemic measuring impact oral oncolytic https://pmc.ncbi.nlm.nih.gov/articles/PMC9365362/ Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent... Testing safety of Delta24-RGD (DNX-2401), an oncolytic adenovirus, locally delivered by convection enhanced delivery (CED) in tumor and surrounding brain of... convection enhanced delivery https://pmc.ncbi.nlm.nih.gov/articles/PMC3989763/ Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity - PMC Oncolytic viruses (OVs) are novel immunotherapeutic agents whose anticancer effects come from both oncolysis and elicited antitumor immunity. OVs induce mostly... https://www.mdpi.com/1999-4915/9/12/382 Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment... Glioblastoma, one of the most aggressive primary brain tumors, is characterized by highly immunosuppressive microenvironment. This contributes to glioblastoma... h 1 immunotherapeutic potential oncolytic parvovirus https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2024.1331369/full Frontiers | Antimetastatic and antitumor activities of oncolytic NDV AMHA1 in a 3D culture model of... Newcastle disease virus (NDV) AMHA1 is capable of killing cancer cells by direct replication or by induction of apoptosis alongside other pathways. Here, we ... https://pmc.ncbi.nlm.nih.gov/articles/PMC8069290/ Oncolytic Virotherapy for Cancer: Clinical Experience - PMC Oncolytic viruses are a new class of therapeutics which are largely in the experimental stage, with just one virus approved by the FDA thus far. While the... oncolytic virotherapy clinical experience cancer pmc https://www.mdpi.com/books/reprint/5203-oncolytic-virus-immunotherapy Oncolytic Virus Immunotherapy | MDPI Books Dear Readers, Oncolytic Viruses (OV) are self-propagating agents that can selectively induce the lysis of cancer cells while sparing normal tissues.... oncolytic virus immunotherapy mdpi books https://www.dukehealth.org/clinical-trials/directory/pro00112883 PuMP: Oncolytic HSV1 MVR-C5252 in... | Clinical Trials at Duke clinical trials pump oncolytic hsv1 mvr https://www.marketresearch.com/Deep-Insights-Research-Co-DIR-v4285/Global-Oncolytic-Virus-Competitive-Landscape-37353786/ Global Oncolytic Virus Competitive Landscape Professional Research Report 2024 Global Oncolytic Virus Competitive Landscape Professional Research Report 2024 Global Oncolytic Virus Competitive Landscape Professional Research Report 2024... oncolytic virus competitive landscape professional research global report https://pmc.ncbi.nlm.nih.gov/articles/PMC5432606/ Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer Cells - PMC Oncolytic viral therapy, which makes use of replication-competent lytic viruses, has emerged as a promising modality to treat malignancies. It has shown... https://www.researchandmarkets.com/reports/6076065/oncolytic-adenovirus-market-report Oncolytic Adenovirus Market Report 2026 - Research and Markets The Oncolytic Adenovirus Market, valued at USD 143.57B in 2026, is projected to reach USD 195.85B by 2030, growing at a 8.1% CAGR. oncolytic adenovirus market report 2026 research markets https://bioimagingcore.be/q2a/tag/oncolytic Recent questions tagged oncolytic - Bioimagingcore Q&A recent questions tagged oncolytic https://www.mdpi.com/1999-4915/13/6/1082 Development of Group B Coxsackievirus as an Oncolytic Virus: Opportunities and Challenges Oncolytic viruses have emerged as a promising strategy for cancer therapy due to their dual ability to selectively infect and lyse tumor cells and to induce... group b https://www.cancer.gov/news-events/cancer-currents-blog/2023/oncolytic-virus-blocking-tgf-beta Oncolytic Virus Disrupts Immune-Blocking Protein - NCI Researchers have modified an oncolytic virus so that it blocks the protein TGF-beta, helping expose tumors to the immune system. oncolytic virus immune blocking protein nci https://pmc.ncbi.nlm.nih.gov/articles/PMC5758921/ Measles virus: Background and oncolytic virotherapy - PMC Measles is a highly transmissible disease caused by measles virus and remains a major cause of child mortality in developing countries. Measles virus... measles virus oncolytic virotherapy background pmc https://www.mdpi.com/2076-393X/12/9/958/notes Vaccines | Free Full-Text | An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for... https://www.news-medical.net/news/20240806/Harnessing-oncolytic-viruses-for-cancer-immunotherapy-to-improve-treatment-outcomes.aspx Harnessing oncolytic viruses for cancer immunotherapy to improve treatment outcomes Aug 6, 2024 - Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target malignant... oncolytic viruses cancer immunotherapy harnessing improve treatment https://pmc.ncbi.nlm.nih.gov/articles/PMC5779534/ Designing and building oncolytic viruses - PMC Oncolytic viruses (OVs) are engineered and/or evolved to propagate selectively in cancerous tissues. They have a dual mechanism of action; direct killing of... oncolytic viruses designing building pmc https://www.precedenceresearch.com/table-of-content/6939 Oncolytic Virus Therapy Market Size to Hit USD 11.13 Billion by 2034 The global oncolytic virus therapy market size is evaluated at USD 3.71 billion in 2025 and is predicted to hit around USD 11.13 billion by 2034, growing at a... oncolytic virus therapy https://pmc.ncbi.nlm.nih.gov/articles/PMC6025169/ Designer Oncolytic Adenovirus: Coming of Age - PMC The licensing of talimogene laherparepvec (T-Vec) represented a landmark moment for oncolytic virotherapy, since it provided unequivocal evidence for the... coming of age oncolytic adenovirus designer pmc https://finviz.com/news/71228/calidi-biotherapeutics-presents-systemic-oncolytic-platform-with-cd55-enhanced-expression-and-il-15-superagonist-payload-at-asco-annual-meeting Calidi Biotherapeutics Presents systemic oncolytic platform with CD55-Enhanced expression and IL-15... Stock screener for investors and traders, financial visualizations. https://informaconnect.com/tilt-arms-oncolytic-viruses-to-enable-t-cell-therapies/ Tilt arms oncolytic viruses to enable T-cell therapies oncolytic viruses tilt arms enable cell https://www.surrey.ac.uk/research-projects/engineering-oncolytic-hsv-optimal-spread-epithelial-ovarian-tumours Engineering oncolytic HSV for optimal spread in epithelial ovarian tumours | University of Surrey https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/oncolytic-virus-therapy.html Oncolytic Virus Therapy and Its Side Effects | American Cancer Society Oncolytic virus therapy uses viruses that have been changed in a lab to destroy cancer cells. Learn more about how they work and their side effects. oncolytic virus therapy side effects american cancer society https://www.epo.org/fr/boards-of-appeal/decisions/t191203eu1 T 1203/19 (Oncolytic adenoviruses/INSTITUT CATALA D'ONCOLOGIA) du 26.04.2022 https://pmc.ncbi.nlm.nih.gov/articles/PMC9761050/ Repeated dosing improves oncolytic rhabdovirus therapy in mice via interactions with intravascular... There is debate in the field of oncolytic virus (OV) therapy, whether a single viral dose, or multiple administrations, is better for tumor control. Using... https://www.precedenceresearch.com/press-release/oncolytic-virus-based-gene-therapy-market Rising Oncology Focus Drives Oncolytic Virus Gene Therapy Market The Oncolytic Virus-Based Gene Therapy Market is expanding rapidly with increasing cancer prevalence, innovative trials, and breakthrough viral platforms. oncology focus oncolytic virus gene therapy rising drives https://pmc.ncbi.nlm.nih.gov/articles/PMC7352900/ Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges - PMC The field of oncolytic virotherapy has seen remarkable advancements in last two decades, leading to approval of the first oncolytic immuno-virotherapy,... oncolytic viral https://www.jpost.com/health-and-wellness/article-846255 Oncolytic viruses: The tiny warriors fighting brain cancer | The Jerusalem Post Oncolytic viruses, once considered medical curiosities, are now cutting-edge tools in the fight against some of the most challenging cancers, like glioblastoma. oncolytic viruses the tiny brain cancer warriors fighting https://pmc.ncbi.nlm.nih.gov/articles/PMC8987060/ Engineering strategies to enhance oncolytic viruses in cancer immunotherapy - PMC Oncolytic viruses (OVs) are emerging as potentially useful platforms in treatment methods for patients with tumors. They preferentially target and kill tumor... oncolytic viruses cancer immunotherapy engineering strategies enhance https://www.biospace.com/press-releases/transgene-and-bioinvent-to-present-updated-data-on-armed-oncolytic-virus-bt-001-at-esmo-2025 Transgene and BioInvent to Present Updated Data on Armed Oncolytic virus BT-001 at ESMO 2025 -... https://www.helsinki.fi/en/researchgroups/immunovirotherapy-lab/news/as-an-expert-in-oncolytic-virotherapy-professor-cerullo-is-ranked-no-13-in-the-world As an expert in Oncolytic Virotherapy Professor Cerullo is ranked no: 13 in the world. |... The founder of Expertscape believes that no one is an expert at anything unless they are investigating the leading edge of knowledge and are writing about it.... https://www.biospace.com/press-releases/calidi-biotherapeutics-presents-systemic-oncolytic-platform-with-cd55-enhanced-expression-and-il-15-superagonist-payload-at-asco-annual-meeting Calidi Biotherapeutics Presents systemic oncolytic platform with CD55-Enhanced expression and IL-15... https://pmc.ncbi.nlm.nih.gov/articles/PMC10213976/ Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers - PMC Nectin4 is a recently discovered tumor associated antigen expressed in cancers that constitute relevant unmet clinical needs, including the undruggable triple... innovative oncolytic herpesvirus positive cancers https://www.dkfz.de/virotherapie/oncolytic-adenovirus-group Oncolytic Adenovirus Group - Deutsches Krebsforschungszentrum oncolytic adenovirus group deutsches https://www.biospace.com/synthetica-pioneering-closes-a-series-a-funding-round-to-support-development-of-oncolytic-bacterial-therapy-for-solid-tumors Synthetica Pioneering Closes a Series A Funding Round to Support Development of Oncolytic Bacterial... https://pmc.ncbi.nlm.nih.gov/articles/PMC5023393/ Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers - PMC We have conducted a phase 1 study of intravenous vvDD, a Western Reserve strain oncolytic vaccinia virus, on 11 patients with standard treatment-refractory... https://pmc.ncbi.nlm.nih.gov/articles/PMC5630504/ Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects - PMC Attenuated Edmonston lineage measles virus (MV-Edm) vaccine strains can preferentially infect and lyse a wide variety of cancer cells. Oncolytic MV-Edm... clinical trials measles virus https://pmc.ncbi.nlm.nih.gov/articles/PMC5472147/ Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and... Pediatric brain tumors including medulloblastoma and atypical teratoid/rhabdoid tumor are associated with significant mortality and treatment-associated... oncolytic herpes virus https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1490414/full Frontiers | Neutrophils in oncolytic virus immunotherapy Oncolytic viruses have emerged as a highly promising modality for cancer treatment due to their ability to replicate specifically within tumors, carry therap... oncolytic virus frontiers neutrophils immunotherapy https://bioimagingcore.be/q2a/204781/oncolytic-virus-therapy-with-ifn Oncolytic Virus therapy with IFN - Bioimagingcore Q&A Oncolytic Virus therapy with IFN from Creative Biolabs. Creative Biolabs provides customized, ... globally. Oncolytic Virus therapy with IFN oncolytic virus therapy ifn q https://pmc.ncbi.nlm.nih.gov/articles/PMC3960873/ Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host - PMC Oncolytic viruses (OVs) replicate selectively in tumor cells and exert anti-tumor cytotoxic activity. Among them, Newcastle Disease Virus (NDV), a bird RNA... newcastle disease virus cutting edge https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2022.819363/full Frontiers | Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy Glioblastoma (GBM), a highly aggressive form of brain tumor, responds poorly to current conventional therapies, including surgery, radiation therapy, and sys... frontiers glioblastoma microenvironment reprogramming oncolytic https://pmc.ncbi.nlm.nih.gov/articles/PMC12730407/ Oncolytic Viruses in Glioblastoma: Clinical Progress, Mechanistic Insights, and Future Therapeutic... Glioblastoma (GBM) is the most aggressive primary brain tumor, with limited treatment options and a poor median survival of around 15 months. Oncolytic viruses... oncolytic viruses glioblastoma clinical https://www.spandidos-publications.com/10.3892/ol.2021.13061 [Retracted] Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation... Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. oncolytic virotherapy reverse transcriptase retracted human telomerase https://www.wikidata.org/wiki/Q45717443 Present status of oncolytic virus studies - Wikidata scientific article published in June 1960 oncolytic virus present status studies wikidata https://pmc.ncbi.nlm.nih.gov/articles/PMC7316762/ Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy... Glioblastoma (GBM) is an immunosuppressive, lethal brain tumor. Despite advances in molecular understanding and therapies, the clinical benefits have remained... oncolytic viruses advances potential pitfalls https://www.mdpi.com/2072-6694/13/3/544 Measles Virus as an Oncolytic Immunotherapy Measles virus (MeV) preferentially replicates in malignant cells, leading to tumor lysis and priming of antitumor immunity. Live attenuated MeV vaccine strains... measles virus oncolytic immunotherapy https://www.mdpi.com/1999-4915/15/2/363 Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo... Oncolytic virotherapy constitutes a promising treatment option for many solid cancers, including peritoneal carcinomatosis (PC), which still represents a... https://www.broadinstitute.org/publications/broad1371471 Retargeted oncolytic viruses engineered to remodel the tumor microenvironment for glioblastoma... oncolytic viruses the tumor engineered https://pmc.ncbi.nlm.nih.gov/articles/PMC8284840/ Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas - PMC Outcomes in children and adolescents with recurrent or progressive high-grade glioma are poor, with a historical median overall survival of 5.6 months.... hsv 1 high grade oncolytic g207 https://pmc.ncbi.nlm.nih.gov/articles/PMC8043042/ Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a... OH2 is a genetically engineered oncolytic herpes simplex virus type 2 designed to selectively amplify in tumor cells and express granulocyte-macrophage... herpes simplex virus 2 https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.839536/full Frontiers | Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions Oncolytic viruses have the capacity to selectively kill infected tumor cells and trigger protective immunity. As such, oncolytic virotherapy has become a pro... senecavirus a https://www.fiercebiotech.com/biotech/merck-inks-394m-takeover-oncolytic-virus-play-viralytics Merck inks $394M takeover of oncolytic virus play Viralytics | Fierce Biotech Feb 21, 2018 - Merck is set to pay $394 million to acquire Viralyti oncolytic virus merck inks takeover https://www.broadinstitute.org/publications/broad1374011 Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus... t cell activation https://pmc.ncbi.nlm.nih.gov/articles/PMC5086626/ Measles to the Rescue: A Review of Oncolytic Measles Virus - PMC Oncolytic virotherapeutic agents are likely to become serious contenders in cancer treatment. The vaccine strain of measles virus is an agent with an... to the rescue a review oncolytic virus measles pmc https://www.mdpi.com/1999-4915/13/6/1019 Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic... Although the oncolytic parvovirus H-1PV has entered clinical trials, predicting therapeutic success remains challenging. We investigated whether the antiviral... https://www.lytixbiopharma.com/ Lytix Biopharma | Oncolytic Immunotherapy Lytix Biopharma is developing first-in-class oncolytic molecule therapies that kill cancer with direct and abscopal tumor effects. Redefining the standard of... lytix biopharma oncolytic immunotherapy https://www.biospace.com/oncomyx-announces-presentation-of-preclinical-efficacy-data-of-novel-oncolytic-immunotherapy-at-sitc-2020 OncoMyx Announces Presentation of Preclinical Efficacy Data of Novel Oncolytic Immunotherapy at... Nov 9, 2020 - OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, announced the presentation of preclinical data at the Society for Immunotherapy of... oncolytic immunotherapy announces presentation preclinical https://pmc.ncbi.nlm.nih.gov/articles/PMC6911943/ Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances - PMC Oncolytic viruses (OVs) are powerful new therapeutic agents in cancer therapy. With the first OV (talimogene laherparepvec [T-vec]) obtaining US Food and Drug... oncolytic viruses cancer therapy barriers recent advances https://www.gminsights.com/industry-analysis/oncolytic-virotherapy-market Oncolytic Virotherapy Market Size & Share Report, 2032 The oncolytic virotherapy market size was valued at USD 20.1 million in 2023 and is anticipated to showcase growth at 26.9% CAGR from 2024 and 2032 driven by... oncolytic virotherapy market size share report 2032 https://pmc.ncbi.nlm.nih.gov/articles/PMC7352817/ Efficacy and Safety of Oncolytic Viruses in Randomized Controlled Trials: A Systematic Review and... Oncolytic virotherapy is a promising antitumor therapeutic strategy. It is based on the ability of viruses to selectively kill cancer cells and induce host... efficacy and safety randomized controlled trials